切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2018, Vol. 12 ›› Issue (02) : 95 -97. doi: 10.3877/cma.j.issn.1674-0785.2018.02.007

所属专题: 文献

临床研究

阿尔茨海默病患者血浆长链非编码RNA51A水平及其与认知功能的相关性
吕峥1, 贝玉章1, 卜桂文1, 邓亮1, 肖乐2, 邓炎尧2,()   
  1. 1. 410300 浏阳市集里医院神经内科
    2. 410005 长沙市第一医院神经医学中心
  • 收稿日期:2017-08-11 出版日期:2018-01-15
  • 通信作者: 邓炎尧

Relationship between plasma level of long non-coding RNA51A and cognitive function in patients with Alzheimer′s disease

Zheng Lyu1, Yuzhang Bei1, Guiwen Bu1, Liang Deng1, Le Xiao2, Yanyao Deng2,()   

  1. 1. Department of Neurology, the Jili Hospital of Liuyang, Liuyang 410300, China
    2. Nerve Medical Center, the First Hospital of Changsha, Changsha 410005, China
  • Received:2017-08-11 Published:2018-01-15
  • Corresponding author: Yanyao Deng
  • About author:
    Corresponding author: Deng Yanyao, Email:
引用本文:

吕峥, 贝玉章, 卜桂文, 邓亮, 肖乐, 邓炎尧. 阿尔茨海默病患者血浆长链非编码RNA51A水平及其与认知功能的相关性[J]. 中华临床医师杂志(电子版), 2018, 12(02): 95-97.

Zheng Lyu, Yuzhang Bei, Guiwen Bu, Liang Deng, Le Xiao, Yanyao Deng. Relationship between plasma level of long non-coding RNA51A and cognitive function in patients with Alzheimer′s disease[J]. Chinese Journal of Clinicians(Electronic Edition), 2018, 12(02): 95-97.

目的

探讨阿尔茨海默病患者血浆长链非编码RNA51A(lncRNA51A)水平及其与认知功能改变的关系。

方法

对2014年6月至2017年6月在长沙市第一医院神经医学中心及浏阳市集里医院神经内科70例阿尔茨海默病(AD)患者及70名非AD健康体检者血浆样本采用实时荧光定量聚合酶链式反应(qRT-PCR)检测血浆lncRNA51A水平,对2组患者血浆lncRNA51A水平予以t检验,同时,进一步采用Spearman相关性分析AD患者血浆lncRNA51A水平与简易精神状态量表(MMSE)评分的相关性。

结果

(1)AD组血浆lncRNA51A水平高于对照组,差异具有统计学意义(4.79±1.05 vs 0.82±0.22,t=30.74,P<0.001)。(2)血浆lncRNA51A水平与MMSE评分呈负相关性(r=-0.204,P<0.001)。

结论

阿尔茨海默病患者血浆lncRNA51A水平增高,阿尔茨海默病患者血浆lncRNA51A水平可以反映认知功能损害的程度。

Objective

To examine the relationship between plasma level of long non-coding RNA 51A (lncRNA 51A) and the change in cognitive function in patients with Alzheimer′s disease (AD).

Methods

Plasma samples were obtained from 70 AD patients and 70 healthy controls from June 2014 to June 2017 at the Department of Neurology of the Jili Hospital of Liuyang and Nerve Medical Center of the First Hospital of Changsha. Plasma levels of lncRNA 51A were measured by real-time quantitative reverse transcriptase PCR (qRT-PCR) and compared between the two groups by the t-test. The correlation between the Mini Mental State Examination (MMSE) scores and the levels of plasma lncRNA 51A in AD patients was analyzed by Spearman correlation.

Results

Plasma lncRNA 51A level in AD patients was significantly higher than that in controls (t=30.74, P<0.001). Plasma lncRNA 51A was negatively correlated with the MMSE scores in AD patients (r=-0.204, P<0.001).

Conclusion

Plasma lncRNA 51A levels increase in AD patients. The degree of cognitive impairment in AD patients can be reflected by the level of plasma lncRNA 51A.

表1 2组患者一般临床资料比较
1
Behl C. The search for novel avenues for the therapy and prevention of Alzheimer′s disease [J]. Drug News Perspect, 2006, 19(1): 5-12.
2
Maruyama R, Suzuki H. Long noncoding RNA involvement in cancer [J]. BMB reports, 2012, 45(11): 604-611.
3
Tinzl M, Marberger M, Horvath S, et al. DD3PCA3 RNA analysis in urine-a new perspective for detecting prostate cancer [J]. Eur Urol, 2004, 46(2): 182-186.
4
Arita T, Ichikawa D, Konishi H, et al. Circulating long non-coding RNAs in plasma of patients with gastric cancer [J]. Anticancer Res, 2013, 33(8): 3185-3193.
5
Isin M, Ozgur E, Cetin G, et al. Investigation of circulating lncRNAs in B-cell neoplasms [J]. Clin Chim Acta, 2014, 431: 255-259.
6
Arita T, Ichikawa D, Konishi H, et al. Circulating long non-coding RNAs in plasma of patients with gastric cancer [J]. Anticancer Res, 2013, 33(8): 3185-3193.
7
Tong YS, Wang XW, Zhou XL, et al. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma [J]. Mol Cancer, 2015, 14: 3.
8
Ren S, Wang F, Shen J, et al. Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer [J]. Europ J Cancer, 2013, 49(13): 2949-2959.
9
Ciarlo E, Massone S, Penna I, et al. An intronic ncRNA-dependent regulation of SORL1 expression affecting Abeta formation is upregulated in post-mortem Alzheimer′s disease brain samples [J]. Dis Model Mech, 2013, 6(2): 424-433.
[1] 蒋庆梅, 巫韧, 杨岸, 陈晓艳, 钟庆. 对囊周神经阻滞在股骨粗隆间骨折患者全麻术中的镇痛效果及认知功能影响的分析[J]. 中华损伤与修复杂志(电子版), 2023, 18(03): 204-209.
[2] 李大伟, 吴宏飞, 韩鹏, 孙盼盼, 邢红伟. 静脉-吸入复合麻醉与全静脉麻醉在老年腹腔镜疝修补术中应用效果比较[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(04): 458-462.
[3] 林静, 陈芳, 刘小霞. COPD患者认知功能障碍影响因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 569-571.
[4] 陈静, 张春明, 周斌, 吴明明. 不同负荷剂量右美托咪定联合酮咯酸氨丁三醇对胸腔镜肺癌根治术后疼痛和认知功能的影响[J]. 中华肺部疾病杂志(电子版), 2023, 16(01): 86-88.
[5] 王洋洋, 徐如祥. 四面体框架核酸在颅脑损伤和阿尔兹海默病认知功能障碍中的治疗作用[J]. 中华神经创伤外科电子杂志, 2022, 08(06): 321-323.
[6] 吴新高, 李伟, 马俊, 刘红, 黄平. 癫痫患者定量脑电图功率谱相关参数与认知功能损伤的相关性研究[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(05): 304-308.
[7] 王姗姗, 徐小汝, 史振仙, 张德杰. 丹参多酚酸联合尤瑞克林治疗急性分水岭脑梗死的疗效及对认知功能、脑血流动力学和血清LPA、ox-LDL、MMP-9水平的影响[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(03): 142-149.
[8] 郭翃江, 符雪彩, 朱妍妍, 严之红, 王丽娜, 纪红. 基于影响因素的老年阿尔茨海默病认知功能障碍预测模型构建及电子化认知康复训练的应用价值[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(03): 156-161.
[9] 孔祥增, 李艳敏, 孟莉, 刘娜, 邱会卿, 王晓. S100β、缺血修饰白蛋白、热休克蛋白70在脑小血管病认知功能损害中的表达及相关性研究[J]. 中华临床医师杂志(电子版), 2023, 17(01): 58-62.
[10] 胡艳, 汪卫华, 纪菊英, 周蓉, 刘羽, 隋云川, 赵汉清, 刘康, 胡一帆. 文拉法辛初始联合坦度螺酮治疗重性抑郁障碍的临床研究[J]. 中华临床医师杂志(电子版), 2022, 16(08): 725-731.
[11] 姚珍珍, 陈昂昂, 周亚楠, 赵高峰, 张申帅, 翟金国, 陈敏. 精神分裂症认知功能损害的特点、机制及干预方式研究进展[J]. 中华诊断学电子杂志, 2023, 11(01): 28-32.
[12] 刘澳, 周菁, 孙永兵, 和俊雅, 林新贝, 乔琦, 李中林, 张建成, 武肖玲, 邹智, 胡扬喜, 肖新广, 吕雪, 李昊, 李永丽. 减重代谢手术后神经影像改变与认知功能评估的研究进展[J]. 中华肥胖与代谢病电子杂志, 2023, 09(03): 203-208.
[13] 刘感哲, 艾芬. MiRNA-210通过抑制HIF-1α的表达改善大鼠血管性认知功能障碍[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 489-494.
[14] 刘天姿, 王宝军. Toll样受体4在阿尔茨海默病中的研究进展[J]. 中华脑血管病杂志(电子版), 2023, 17(04): 404-409.
[15] 夏禹, 刘寒, 朱瑞. 阿尔茨海默病及相关认知障碍疾病与早老素2基因相关性的研究进展[J]. 中华脑血管病杂志(电子版), 2023, 17(03): 290-293.
阅读次数
全文


摘要